Поисковый запрос: (<.>S=РИФАПЕНТИН<.>) |
Общее количество найденных документов : 25
Показаны документы с 1 по 20
|
|
1.
| Liu Фармакокинетика и связанная с ней биодоступность рифапентина // Zhongguo yaoxue zazhi, 1996. Vol. 31, N 5.-С.291-294
|
2.
| Heifets L. Drug combinations against mycobacteria in human macrophages // Int. J. Tuberc. and Lung Disease, 1998. Vol. 2, N 11 Suppl. n2.-С.170
|
3.
| Heifets L. Drug combinations against mycobacteria in human macrophages // Int. J. Tuberc. and Lung Disease, 1998. Vol. 2, N 11 Suppl. n2.-С.170
|
4.
| Mitchison D.A. Development of rifapentine: THe way ahead // Int. J. Tuberc. and Lung Disease, 1998. Vol. 2, N 8.-С.612-615
|
5.
| Shoen Carolyn M. Durable cure for tuberculosis: Rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infection // Clin. Infec. Diseases, 2000. Vol. 30, прил. N 3.-С.288-290
|
6.
| Shoen Carolyn M. Durable cure for tuberculosis: Rifalazil in combination with isoniazid in a murine model of Mycobacterium tuberculosis infection // Clin. Infec. Diseases, 2000. Vol. 30, прил. N 3.-С.288-290
|
7.
| Population pharmacokinetics of rifapentine and its primary desacetyl metabolite in South African tuberculosis patients // Antimicrob. Agents and Chemother., 2005. Vol. 49, N 11.-С.4429-4436
|
8.
| Population pharmacokinetics of rifapentine and its primary desacetyl metabolite in South African tuberculosis patients // Antimicrob. Agents and Chemother., 2005. Vol. 49, N 11.-С.4429-4436
|
9.
| Новый противотуберкулезный препарат рифапекс // Туберкулез и болезни легких, 2009, N 11.-С.61-64
|
10.
| Новый противотуберкулезный препарат рифапекс // Туберкулез и болезни легких, 2009, N 11.-С.61-64
|
11.
| Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations // Antimicrob. Agents and Chemother., 2008. Vol. 52, N 11.-С.4037-4042
|
12.
| Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations // Antimicrob. Agents and Chemother., 2008. Vol. 52, N 11.-С.4037-4042
|
13.
| Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentine // Antimicrob. Agents and Chemother., 2012. Vol. 56, N 8.-С.4471-4473
|
14.
| Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentine // Antimicrob. Agents and Chemother., 2012. Vol. 56, N 8.-С.4471-4473
|
15.
| Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteers // Antimicrob. Agents and Chemother., 2010. Vol. 54, N 8.-С.3390-3394
|
16.
| Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteers // Antimicrob. Agents and Chemother., 2010. Vol. 54, N 8.-С.3390-3394
|
17.
| Torlotin J.C. Chimiotherapie des infections a mycobacteries. Lepre exclue // J. pharm. clin., 1988. Vol. 7, N 1.-С.127-135
|
18.
| Actividad in vitro de clofacimina aisladamente y en asociacion con amikacina, roxitromicina, rifampicina y rifapentina frente a Mycobacterium avium-intracellulare // Enferm. infecc. y microbiol. clin., 1989. Vol. 7, N 8.-С.432-435
|
19.
| Liu Inductive effects of rifapentine on mice hepatic mixed function oxidase system // Meth. and Find. Exp. and Clin. Pharmacol, 1990. Vol. 12, N 2.-С.903-913
|
20.
| Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis // Tubercle and Lung Disease., 1992. Vol. 73, N 2.-С.116-123
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"